| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.082 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.088 | 0.7 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |